| Citation: | LIU Chuang, DU Jianmin, QIN Ge, LUO Xiaohua, HAN Ning. A randomized controlled trial of dinoprostone vaginal suppository versus double-balloon catheter for labor induction in term pregnancies with hypertension[J]. Chinese Journal of General Practice, 2026, 24(5): 735-738. doi: 10.16766/j.cnki.issn.1674-4152.004479 |
| [1] |
LI F, QIN J B, ZHANG Y, et al. Prevalence of hypertensive disorders in pregnancy in China: a systematic review and meta-analysis[J]. Pregnancy Hypertens, 2021, 24: 13-21. doi: 10.1016/j.preghy.2021.02.001
|
| [2] |
VESNA D, GAROVIC R, JOHNSON J, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association[J]. Hypertension, 2022, 79(2): e21-e41.
|
| [3] |
SHANMUGALINGAM R, MAKRIS A. A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline[J]. Med J Aust, 2025, 222(3): 158-159.
|
| [4] |
汪文昕, 汪若兰, 方媛媛, 等. 妊娠期高血压疾病单胎妊娠并发胎盘早剥的风险预测[J]. 中华全科医学, 2024, 22(8): 1367-1370. doi: 10.16766/j.cnki.issn.1674-4152.003638
WANG W X, WANG R L, FANG Y Y, et al. Risk prediction of placental abruption in singleton pregnancy with hypertensive disorders of pregnancy[J]. Chinese Journal of General Practice, 2024, 22(8): 1367-1370. doi: 10.16766/j.cnki.issn.1674-4152.003638
|
| [5] |
ALLARD M, MARTIN S, DUVAL C, et al. Prévention de la prééclampsie et de ses complications[J]. Rev Med Liege, 2024, 79(5-6): 448-454.
|
| [6] |
MAGEE L A, BROWN M A, PATERSON J, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2022, 27: 148-169. doi: 10.1016/j.preghy.2021.09.008
|
| [7] |
TSAKIRIDIS I, MAMOPOULOS A, KARAVASILIS N, et al. Gestational hypertension and preeclampsia: an overview of national and international guidelines[J]. Obstet Gynecol Surv, 2021, 76(10): 613-633. doi: 10.1097/OGX.0000000000000942
|
| [8] |
中华医学会妇产科学分会产科学组. 妊娠晚期促子宫颈成熟与引产指南(2024)[J]. 中华妇产科杂志, 2024, 59(11): 819-828.
Obstetrics Group, Obstetrics and Gynecology Branch of Chinese Medical Association. Guideline of cervical ripening and labor induction during the third trimester pregnancy (2024)[J]. Chinese Journal of Obstetrics and Gynecology, 2024, 59(11): 819-828.
|
| [9] |
National Institute for Health and Care Excellence. Inducing labour[M]. London: National Institute for Health and Care Excellence, 2021: 1-45.
|
| [10] |
方艳, 王群华, 陈红波. 妊娠期高血压疾病的早期预测模型构建[J]. 现代妇产科进展, 2024, 33(7): 506-511.
FANG Y, WANG Q H, LI J, et al. Construction of early prediction model for hypertensive disorders in pregnancy[J]. Progress in Obstetrics and Gynecology, 2024, 33(7): 506-511.
|
| [11] |
陈鸳鸳, 马建婷. 人口学、血常规及血清生化指标预测妊娠期高血压疾病的价值分析[J]. 中华全科医学, 2025, 23(3): 430-433.
CHEN Y Y, MA J T, ZHANG M. The value of demography, blood routine and serum biochemical indexes in predicting hypertensive disorder complicating pregnancy[J]. Chinese Journal of General Practice, 2025, 23(3): 430-433.
|
| [12] |
张莉莉, 关丫丫, 张林波. 血清同型半胱氨酸、中性粒细胞明胶酶相关脂质运载蛋白联合尿微量白蛋白对妊娠期高血压疾病患者早期肾损伤的诊断价值[J]. 新乡医学院学报, 2022, 39(2): 177-181.
ZHANG L L, GUAN Y Y, WANG J. Diagnostic value of serum homocysteine, neutrophil gelatinase-associated lipid carrier protein and urinary microalbumin for early renal injury of patients with hypertensive disease of pregnancy[J]. Journal of Xinxiang Medical University, 2022, 39(2): 177-181.
|
| [13] |
PIEUX A, DE L F, MOREAU M, et al. Uterine hyperstimulation in cervical ripening with oral misoprostol versus dinoprostone vaginal pessary: a real-life single-center descriptive study[J]. J Gynecol Obstet Hum Reprod, 2025, 54(5): 102944. DOI: 10.1016/j.jogoh.2024.102944.
|
| [14] |
COLVIN Z, FENG M, WANG Y, et al. Duration of labor induction in nulliparous women with hypertensive disorders of pregnancy and maternal and neonatal outcomes[J]. J Matern Fetal Neonatal Med, 2022, 35(20): 3964-3971. doi: 10.1080/14767058.2020.1844658
|
| [15] |
CARVALHO-AFONSO M, POLICIANO C, CLODE N, et al. Cervical ripening with Foley catheter balloon: a prospective cohort of 320 women[J]. Int J Gynaecol Obstet, 2025, 170: 768-773. doi: 10.1002/ijgo.70088
|
| [16] |
LI S Y, HE H, ZHAO J, et al. Comparison of outcomes of labor induction with dinoprostone vaginal insert (PROPESS) and double balloon cook catheter in term nulliparous pregnancies[J]. J Obstet Gynaecol Res, 2025, 51: e16107. DOI: 10.1016/j.ajoggr.2023.100198.
|
| [17] |
LU Y, JING P, ZHAO H, et al. Efficacy and safety of double balloon catheter and dinoprostone for labor induction in multipara at term[J]. Arch Gynecol Obstet, 2023, 309: 1235-1243.
|
| [18] |
CANADAS J V, LOPEZ M, MARTINEZ M, et al. Intracervical double-balloon catheter versus dinoprostone for cervical ripening in labor induction in pregnancies with a high risk of uterine hyperstimulation[J]. Arch Gynecol Obstet, 2021, 304(6): 1475-1484. doi: 10.1007/s00404-021-06071-1
|
| [19] |
TAKAKURA S, TANAKA H, ENOMOTO N, et al. The successful use of nitroglycerin for uterine hyperstimulation with fetal heart rate abnormality caused by a controlled-release dinoprostone vaginal delivery system (propess): a case report[J]. Medicina (Kaunas), 2021, 57(5): 478-478. doi: 10.3390/medicina57050478
|
| [20] |
YANG C, QIAN L L, ZHANG Y, et al. Comparison of the efficacy and safety of dinoprostone and double-balloon catheters in cervical ripening: a propensity score matching retrospective study[J]. Ginekol Pol, 2024, 96: 161-167.
|
| [21] |
ALICIA R, RODRIGUEZ Z, SANTAMARIÑA E, et al. Effectiveness and safety of the double intracervical balloon vs dinoprostone in patients with previous cesarean section[J]. Reprod Sci, 2024, 31: 3148-3158. doi: 10.1007/s43032-024-01617-5
|